Biomerica Stock Price (NASDAQ:BMRA)

Add to My Stocks
$3.37 $0.02 (0.59%) BMRA stock closing price Sep 19, 2018 (Closing)
Prev Close* : $3.39
Market Cap:
$30.35M
Day Low: $3.32
52 Week Low: $2.68
Open: $3.39
Volume: -
Day High: $3.41
52 Week High: $9.32
Dividend:
0.00

Latest Stock Market News

Latest Articles

Biomerica News - From Partners

Biomerica Announces Third Quarter Financial Results   by Globe Newswire on Apr 17, 2018

BMRA Stockcharts

View BMRA PE ratio, PS ratio stocks charts and compare with peers.
BMRA Chart
Note: Compare Biomerica stock price history with the index and industry peers.

Biomerica Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
5.05
PB ratio (
price to book ratio
)
6.67

Biomerica Returns

ROE
(return on equity)
-35%

Biomerica Financial Ratios

Asset Turnover
0.91
Receivables Turnover
5.46
Debt to Equity
0
Dividend Yield
0%

BMRA Industry Peers

Company Price Change (%)
Avenue Theraptc (ATXI)3.270.26 (7.37%)
Ait Therapeutic (AITB)40 (0%)
Align Technology (ALGN)379.946.02 (1.56%)
Dentsply Sirona (XRAY)38.610.42 (1.1%)
Sirona Dental Systems (SIRO)109.970 (0%)
Align Technology (ALGN)379.946.02 (1.56%)
Dentsply Sirona (XRAY)38.610.42 (1.1%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Biomerica, Inc. Stock News - Partner Headlines

Biomerica Financial Statements

income statement20172016201520142013
Net Sales or Revenues5.79M5.13M4.96M5.12M6.47M
Net Income-0.9M-1.49M-0.33M-0.21M-
Total Operating Expense2.97M1.57M1.47M1.52M1.45M
View Biomerica income statement
balance sheet20172016201520142013
Total Assets5.01M5.72M6.12M6.47M6.39M
Total Liabilities-----
Shareholders Equity4.48M5.22M5.6M5.91M5.83M
View Biomerica balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.08M--0.01M-0.52M-
Net Cash from (used by) Operating Activities-0.72M-0.2M-0.4M-0.86M1.39M
Increase (Decrease) in Prop Plant And Equipment-0.09M-0.09M-0.01M-0.13M-0.25M
View Biomerica cash flow statement

Biomerica Stock Message Board

Biomerica stock price ended the last trading day at $3.37. The total market value as denoted by $30.35M for Biomerica, is the market value of the company's outstanding shares. Biomerica valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy BMRA stock than sell it, then Biomerica stock price goes up. Conversely, if more investors wanted to sell BMRA stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 14,511 on the last trading day, as is evident from Biomerica stock chart, and BMRA stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Biomerica dividend per share was 0.00 during the last quarter. Biomerica stock price history, gives the entire historical data for BMRA stock.